Symposium

PERCHLORATE EXPOSURES, IODINE MODULATION OF EFFECT,
AND EPIDEMIOLOGIC ASSOCIATIONS: IMPLICATIONS FOR RISK ASSESSMENT

An Ancillary Program of the Annual Meeting of the Society of Toxicology

Sponsored by: the Kleinfelder Group

Endorsed by: Toxicology Excellence for Risk Assesment

Dedicated in fond memory of Professor Monte Greer

Thursday, March 20, 1:00 PM – 4:30 PM
Friday, March 21, 9:00 AM – 3:30 PM

Seattle Sheraton Hotel, 1400 6th Avenue, Seattle, Washington 98101

Participant Affiliations

Yona Amitai, MD, MPH	Director, Department of Mother, Child & Adolescent Health, Ministry of Health, Jerusalem; Associate Professor of Pediatrics, Hebrew University-Hadassah, Jerusalem, Israel.
Benjamin C. Blount, PhD	Research Chemist, Centers for Disease Control and Prevention, Atlanta, GA.
Lewis E. Braverman, MD	Professor of Medicine, Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine and Medical Center, Boston, MA.
Gregory A. Brent, MD	Chief, Endocrinology and Diabetes Section, VA Greater Los Angeles Healthcare System; Professor of Medicine and Physiology, David Geffen School of Medicine, UCLA, Los Angeles, CA.
Michael L. Dourson, PhD, DABT	Director, Toxicology Excellence for Risk Assessment, Cincinnati, OH.
John P. Gibbs, MD	Consultant in occupational health, Wimberley, TX.
Gay Goodman, PhD, DABT	Practice Leader, Toxicology & Health Risk Assessment, The Kleinfelder Group, Bellevue, WA.
Robert A. Howd, PhD	Chief, Water Toxicology Section, Office of Environmental Health Hazard Assessment, Cal/EPA, Oakland, CA.
Steven H. Lamm, MD, MPH	President, Consultants in Epidemiology and Occupational Health, Inc., Washington, DC.
Elizabeth N. Pearce, MD	Asst. Professor of Medicine, Section of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, Boston, MA.
David A. Stonestrom, PhD	Research Hydrologist, U.S. Geological Survey, Menlo Park, CA.